• U. Boeken
  • A. Assmann
  • F. Born
  • C. Schmid


Bei der Technik der intraaortalen Gegenpulsation (IABP) handelt es sich um die einfachste invasive Form der mechanischen Kreislaufunterstützung (MKU). Eine IABP ist in nahezu allen kardiologischen und kardiochirurgischen Kliniken verfügbar, sie ist schnell bettseitig einsetzbar, effektiv, verhältnismäßig kostengünstig und ein komplikationsarmes Verfahren.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


Literatur zu 3.1

  1. Briguori C, Sarais C, Pagnotta P, Airoldi F, Liistro F et al (2003) Elective versus provisional intraaortic balloon pumping in high-risk percutanous transluminal coronary angioplasty. Am Heart J 145: 700-707PubMedCrossRefGoogle Scholar
  2. Christenson JT, Simonet F, Badel P, Schmuziger M (1999) Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients. Ann Thorac Surg 68: 934-939PubMedCrossRefGoogle Scholar
  3. Collison SP, Dagar KS (2007) The role of intraaortic balloon pump in supporting children with acute cardiac failure. Postgrad Med J 83: 308-311CrossRefGoogle Scholar
  4. Craver JM, Murrah CP (2001) Elective intraaortic balloon counterpulsation for high-risk off-pump coronary artery bypass operations. Ann Thorac Surg 71: 1220-1223PubMedCrossRefGoogle Scholar
  5. Erdogan HB, Goksedef D, Erentug V et al (2006) In which patients should sheathless IABP be used? An analysis of vascular complications in 1211 cases. J Cardiovasc Surg 21(4): 342-346Google Scholar
  6. Ferguson JJ 3rd, Cohen M, Freedman RJ Jr et al (2001) The current practice of intra-aortic balloon counterpulsation: Results from the Benchmark Registry. J Am Coll Cardiol 38(5): 1456-1462PubMedCrossRefGoogle Scholar
  7. Fuchs RM, Brin KP, Brinker JA, Guzman PA, Heuser RR, Yin FC (1983) Augmentation of coronary blood flow by intraaortic balloon counterpulsation in patients with unstable angina. Circulation 68: 117-123PubMedCrossRefGoogle Scholar
  8. Harken DE (1976) Counterpulsation. Med Instrum 10(5): 215PubMedGoogle Scholar
  9. Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J et al for SHOCK Registry Investigators (1995) Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an international registry. Circulation 91: 873-881PubMedCrossRefGoogle Scholar
  10. Kantrowitz A (1953) Experimental augmentation of coronary flow by retardation of the arterial pressure pulse. Surgery 34(4): 678-687PubMedGoogle Scholar
  11. Kantrowitz A, Tjonneland S, Freed PS et al (1968) Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 203(2): 113-118PubMedCrossRefGoogle Scholar
  12. Lindsay AC, Khaghani A, Dalby MCD (2009) Intra-aortic balloon and other counterpulsation techniques In: ISHLT Monograph Series 3, Advanced Heart Failure, Elsevier, Philadelphia London, Toronto Montreal Sydney Tokyo, S 557-568Google Scholar
  13. Marcu CB, Donohue TJ, Ferneini A, Ghantous AE (2006) Intraaortic balloon pump insertion through the subclavian artery. Subclavian artery insertion of IABP Heart Lung Circ 15(2): 148-150CrossRefGoogle Scholar
  14. Moulopoulos SD, Topaz S, Kolff WJ (1962) Diastolic balloon pumping (with carbon dioxide) in the aorta- a mechanical assistance to the failing circulation. Am Heart J 63: 669-675PubMedCrossRefGoogle Scholar
  15. Ohman EM, Califf RM, George BS, Quigley PJ, Kereiakes DJ et al for the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group (1991) The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. Am Heart J 121(3Pt1): 895-901PubMedCrossRefGoogle Scholar
  16. Onorati F, Impiombato B, Ferraro A, Comi MC, Spaccarotella C et al (2007) Transbrachial intraaortic balloon pumping in severe peripheral atherosclerosis. Ann Thorac Surg 84(1): 264-266PubMedCrossRefGoogle Scholar
  17. Santini F, Mazzucco A (1997) Transthoracic intraaortic counterpulsation: A simple method for ballon catheter positioning. Ann Thorac Surg 64: 859-860PubMedCrossRefGoogle Scholar
  18. Stone G, Marsalese D, Brodie B, Griffin J, Donohue B et al (1995a) The routine of intra aortic balloon after primary PTCA improves clinical outcomes in very high-risk patients with acute myocardial infarction: Results of the PAMI-2 Trial (abstract). Circulation 92(I): 139Google Scholar
  19. Stone G, Marsalese D, Brodie B, Griffin J, Donohue B et al (1995b) Is prophylactic IABP use beneficial or harmful in a high risk elderly population with acute myocardial infarction? Results of the PAMI-2 trial (abstract). Circulation 92(I): 139Google Scholar

Literatur zu 3.2

  1. Alasnag MA, Gardi DO, Elder M, Kannam H, Ali F et al (2011) Use of the Impella 2.5 for prophylactic circulatory support during elective high-risk percutaneous coronary intervention. Cardiovasc Revasc Med 12(5): 299-303PubMedCrossRefGoogle Scholar
  2. Alli OO, Singh IM, Holmes DR, Jr., Pulido JN, Park SJ, Rihal CS (2012) Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: The mayo clinic experience. Catheter Cardiovasc Interv 2012 Feb 29. doi: 10.1002/ccd.23465. [Epub ahead of print]Google Scholar
  3. Amico A, Brigiani MS, Vallabini A, Ferrante B, Marzovillo A et al (2008) a new short-term ventricular assist device: our experience in off-pump coronary artery bypass graft surgery. J Cardiovasc Med (Hagerstown) 9(4): 423-426.CrossRefGoogle Scholar
  4. Anastasiadis K, Chalvatzoulis O, Antonitsis P, Tossios P, Papakonstantinou C (2011) Left ventricular decompression during peripheral extracorporeal membrane oxygenation support with the use of the novel iVAC pulsatile paracorporeal assist device. Ann Thorac Surg 92(6): 2257-2259PubMedCrossRefGoogle Scholar
  5. Basra SS, Loyalka P, Kar B (2011) Current status of percutaneous ventricular assist devices for cardiogenic shock. Curr Opin Cardiol 26(6): 548-554PubMedCrossRefGoogle Scholar
  6. Burkhoff D, Cohen H, Brunckhorst C, O’Neill WW (2006) A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 152(3): 469-468PubMedCrossRefGoogle Scholar
  7. Dixon SR, Henriques JP, Mauri L, Sjauw K, Civitello A et al (2009) A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv 2(2): 91-96PubMedCrossRefGoogle Scholar
  8. Froesch P, Martinelli M, Meier P, Cook S, Hullin R, et al (2011) Clinical use of temporary percutaneous left ventricular assist devices. Catheter Cardiovasc Interv 78(2): 304-313PubMedCrossRefGoogle Scholar
  9. Higgins J, Lamarche Y, Kaan A, Stevens LM, Cheung A (2011) Microaxial devices for ventricular failure: a multicentre, population-based experience. Can J Cardiol 27(6): 725-730.PubMedCrossRefGoogle Scholar
  10. Kovacic JC, Nguyen HT, Karajgikar R, Sharma SK, Kini AS (2011) The impella recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention. Catheter Cardiovasc Interv 2011 Jan 13 [Epub ahead of print]Google Scholar
  11. Maini B, Naidu SS, Mulukutla S, Kleiman N, Schreiber T et al (2011) Real-world use of the impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: The uspella registry. Catheter Cardiovasc Interv 2011 Nov 22. doi: 10.1002/ccd.23403. [Epub ahead of print]Google Scholar
  12. Samuels LE, Kaufman MS, Thomas MP, Holmes EC, Brockman SK, Wechsler AS (1999) Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. J Card Surg 14(4): 288-293PubMedCrossRefGoogle Scholar
  13. Schwartz BG, Ludeman DJ, Mayeda GS, Kloner RA, Economides C, Burstein S. (2011) High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience. J Invasive Cardiol 23(10): 417-424PubMedGoogle Scholar
  14. Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L et al (2008) A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intraaortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 52(19): 1584-1588PubMedCrossRefGoogle Scholar
  15. Siegenthaler MP, Brehm K, Strecker T, Hanke T, Notzold A et al (2004) The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience. J Thorac Cardiovasc Surg 127(3): 812-822PubMedCrossRefGoogle Scholar
  16. Tempelhof MW, Klein L, Cotts WG, Benzuly KH, Davidson CJ et al (2011) Clinical experience and patient outcomes associated with the TandemHeart percutaneous transseptal assist device among a heterogeneous patient population. ASAIO J 57(4): 254-261PubMedCrossRefGoogle Scholar
  17. Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G. (2001) Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 104(24): 2917-2922PubMedCrossRefGoogle Scholar

Literatur zu 3.3

  1. Arlt M, Philipp A, Voelkel S, Camboni D, Rupprecht L et al (2011) Hand-held minimised extracorporeal membrane oxygenation: a new bridge to recovery in patients with out-of-centre cardiogenic shock. Eur J Cardiothorac Surg 40(3): 689-694PubMedGoogle Scholar
  2. Arlt M, Philipp A, Voelkel S, Graf BM, Schmid C, Hilker M (2011) Out-of-hospital extracorporeal life support for cardiac arrest-A case report. Resuscitation 82(9): 1243-1245PubMedCrossRefGoogle Scholar
  3. Arlt M, Philipp A, Zimmermann M, Voelkel S, Amann M et al (2009) Emergency Use of Extracorporeal Membrane Oxygenation in Cardiopulmonary Failure. Artifi Org 33(9): 696-703CrossRefGoogle Scholar
  4. Beurtheret S, Mordant P, Paoletti X, Marijon E, Celermajer DS et al (2012) Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program), Eur Heart J 2012, Apr. 17. [Epub ahead of print]Google Scholar
  5. Chen YS, Lin JW, Yu HY, Ko WJ, Jerng JS et al (2008) Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet 372(9638): 554-561PubMedCrossRefGoogle Scholar
  6. Chen YS, Yu HY, Huang SC, Lin JW et al (2008) Extracorporeal membrane oxygenation support can extend the duration of cardiopulmonary resuscitation. Crit Care Med 36: 2529-2535PubMedCrossRefGoogle Scholar
  7. Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL et al (2008) Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock: Crit Care Med 36: 1404-1411PubMedCrossRefGoogle Scholar
  8. Le Guen M, Nicolas-Robin A, Carreira S, Raux M, Leprince P et al (2011) Extracorporeal life support following out-of-hospital refractory cardiac arrest, Critical Care 15: R29PubMedCrossRefGoogle Scholar
  9. Lin JW, Wang MJ, Yu HY, Wang CH, Chang WT et al (2010) Comparing the survival between extracorporeal rescue and conventional resuscitation in adult in-hospital cardiac arrests: Propensity analysis of three-year data. Resuscitation 81(7): 796-803PubMedCrossRefGoogle Scholar
  10. Massetti M, Tasle M, Le Page O, Deredec R, Babatasi G et al (2005) Back from Irreversibility: Extracorporeal Life Support for Prolonged Cardiac Arrest. Ann Thorac Surg 79: 178-183PubMedCrossRefGoogle Scholar
  11. Peek GJ (2011) Community extracorporeal life support for cardiac arrest - When should it be used? Resuscitation 82: 1117 editorialPubMedCrossRefGoogle Scholar
  12. Ranucci M, Ballotta A, Kandil H, Isgrö G, Carlucci C et al for the Surgical and Clinical Outcome Research Group (2011) Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation. Critical Care 15: R275CrossRefGoogle Scholar
  13. Thiagarajan RR, Brogan TV, Scheurer MA, Laussen PC, Rycus PT, Bratton SL (2009) Extracorporeal Membrane Oxygenation to Support Cardiopulmonary Resuscitation in Adults. Ann Thorac Surg 87:778-85PubMedCrossRefGoogle Scholar

Literatur zu 3.4

  1. Chen et al (2009) CPR vs ECPR for in hospital Cardiac Arrset (Taiwan) LancetGoogle Scholar
  2. Coppola CP, Tyreeb M, Larryb K, Di Geronimob R (2008) A 22-year experience in global transport extracorporeal membrane oxygenation. J Ped Surg 43, 46-52CrossRefGoogle Scholar
  3. Nichol G, Thomas E, Callaway CW et al (2008) Regional Variation in Out-of-Hospital Cardiac Arrest Incidence and Outcome, Jama 300(12)1423-1431 EASA, www.easa.europa.euPubMedCrossRefGoogle Scholar
  4. Bartlett R, Gattinoni L (2010) Current status of extracorporeal life support (ECMO) for cardiopulmonary failure. Minerva Anestesiol 76 (7): 534-540PubMedGoogle Scholar
  5. Schmid C, Philipp A, Müller T, Hilker M (2009) Extracorporeal Life Support Systems, Indications and Limitations. Thorac Cardiovasc Surg 57: 449-454PubMedCrossRefGoogle Scholar
  6. Bisdas T, Beutel G, Warnecke G et al (2011) Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation support. Ann Thorac Surg 92(2):626-631, Epub 2011 May 8CrossRefGoogle Scholar
  7. Berdajs D, Born F, Crosset M et al (2010) Superior venous drainage in the „Life Box»: a portable extracorporeal oxygenator with a self-expanding venous cannula. Perfusion 25: 211-215 Scholar
  8. Güngerich A,(2010) Ein Herz will weiterschlagen. 1414 Gönnermagazin der Schweizerischen Rettungsflugwacht 74: 12-13Google Scholar
  9. Born F, Ammann U, Burren T, Albrecht R et al (2010) Transatlantikflug mit transportabler HerzLungen-Maschine «LifeBox«, Kardiotechnik (3): 65-69Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • U. Boeken
    • 1
  • A. Assmann
    • 1
  • F. Born
    • 2
  • C. Schmid
    • 3
  1. 1.Klinik für Kardiovaskuläre ChirurgieUniversitätsklinikum DüsseldorfDüsseldorf
  2. 2.Herzchirurgische Klinik und PoliklinikKlinikum der Universität München – GroßhadernMünchen
  3. 3.Klinik für Herz-, Thorax- und herznahe GefäßchirurgieUniversitätsklinikum RegensburgRegensburg

Personalised recommendations